Correction: SARS-CoV-2 antibody seroprevalence in
Togo: a national cross-sectional household survey,
May-June, 2021

Yao Rodion Konu, Siaka Conde, Fifonsi Gbeasor-Komlanvi, Arnold Junior Sadio, Martin Kouame Tchankoni, Joel Anani, Alexandra Bitty-Anderson, Bisimwa Ruhana Mirindi, Fatoumata Binta Tidiane Diallo, Moustapha Mijiyawa, et al.

<figure><img src="image_1.png" /></figure>

To cite this version:

Yao Rodion Konu, Siaka Conde, Fifonsi Gbeasor-Komlanvi, Arnold Junior Sadio, Martin Kouame Tchankoni, et al. Correction: SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May-June, 2021. BMC Public Health, 2023, 23 (1), 10.1186/s12889-023-15004-3. hal-04000807

HAL Id: hal-04000807

https://hal.science/hal-04000807

Submitted on 22 Feb 2023

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_3.png" /></figure>

Check for
updates

# Correction: SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021

Yao Rodion Konu<sup>1,2,3,4</sup>, Siaka Condé<sup>5</sup>, Fifonsi Gbeasor-Komlanvi<sup>2,3,4</sup>, Arnold Junior Sadio<sup>2,3,4</sup>, Martin Kouame Tchankoni<sup>2,3,4</sup>, Joel Anani<sup>5</sup>, Alexandra Bitty-Anderson<sup>1,4</sup>, Bisimwa Ruhana Mirindi<sup>5</sup>, Fatoumata Binta Tidiane Diallo<sup>5</sup>, Moustapha Mlijiyawa<sup>6</sup>, Anoumou Claver Dagnra<sup>7†</sup> and Didier Koumavi Ekouevi<sup>1,2,3,4*†</sup>

Correction: BMC Public Health 22, 2294 (2022)
https://doi.org/10.1186/s12889-022-14794-2

The original publication [1] of this paper contained a typo in the abstract. The value "CI95%: 18.9–21.1" should have been "95%CI: 64.3–66.6". This was correct elsewhere in the article. The original article has been updated to correct this.

Published online: 27 January 2023

Reference

1. Konu YR, et al. SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021. BMC Public Health. 2022;22:2294. https://doi.org/10.1186/s12889-022-14794-2.

The original article can be found online at https://doi.org/10.1186/s12889-022-14794-2.

<footnote>†Anoumou Claver Dagnra and Didier Koumavi Ekouevi contributed equally to this work.</footnote>

<footnote>*Correspondence:
Didier Koumavi Ekouevi
didier.ekouevi@gmail.com</footnote>

<footnote n="1">¹ Bordeaux Population Health Centre, UMR 1219, University of Bordeaux, National Institute for Health and Medical Research (INSERM), Research Institute for Sustainable Development (IRD), Bordeaux, France</footnote>

<footnote n="2">² Département de Santé Publique, Université de Lomé, Lomé, Togo</footnote>

<footnote n="3">³ Centre de Recherche et de Formation en Santé Publique (CFRSP), Université de Lomé, Lomé, Togo</footnote>

<footnote n="4">⁴ Centre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo</footnote>

<footnote n="5">⁵ Togo Office, World Health Organization (WHO), Lomé, Togo</footnote>

<footnote n="6">⁶ Ministère de la Santé, de l'Hygiène Publique et de l'accès universel aux soins, Lomé, Togo</footnote>

<footnote n="7">⁷ Laboratoire de Biologie Moléculaire et d'Immunologie (BIOLIM), Université de Lomé, Lomé, Togo</footnote>